Randomized Sham-controlled Trials in Endoscopy: a Systematic Review and Meta-analysis of Adverse Events

Overview

Journal Gastrointest Endosc

Specialties Gastroenterology
Pharmacology
Radiology

Date 2017 Aug 14

PMID 28802556

Citations 2

Authors

Allison R Schulman

Violeta Popov

Christopher C Thompson

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Sham procedures in endoscopy are used with the intention of controlling for placebo response, potentially allowing more precise evaluation of treatment effect. Nevertheless, this type of study may impose significant risk without potential benefit for those in the sham group. The aim of the current study was to systematically review and analyze the endoscopic literature to assess the safety of sham controls.

Methods: MEDLINE and Embase databases were searched for endoscopic sham procedures for all dates to July 2017. Only randomized controlled trials comparing an endoscopic therapy with a sham were included. Primary outcome was adverse events (AEs) categorized as mild, moderate, or severe. Results were combined using a random-effects model. Heterogeneity was assessed with the I statistic, and publication bias was assessed with the Egger test and funnel plots.

Results: Data were extracted from 34 publications (1987-2017; 100% full text), with a total of 2492 procedures (1355 treatment/1137 sham). Sham procedures involved upper endoscopy (31 studies) and ERCP (3 studies). Treatment arms included procedures with the following indications: weight loss (38.2%), GI bleeding (26.5%), GERD (20.6%), sphincter of Oddi dysfunction (8.8%), and dysphagia (6.2%). Overall percentage of severe adverse events (SAEs) in the sham group was 1.7% (19/1137). Of these, the most common SAEs in the sham groups were need for surgery/intensive care unit stay (35.3%), post-ERCP pancreatitis (23.5%), and perforation (11.8%). There was no significant difference in the odds of developing an SAE between the treatment group and the sham group (odds ratio, 1.3; 95% confidence interval [CI], 0.7-2.3). The pooled additional risk incurred from being initially randomized to the sham arm and then receiving a cross-over intervention was significant (RR, 1.33; 95% CI, 1.14-1.56; P < .001), compared with patients initially randomized to the study intervention.

Conclusion: The frequency of AEs in endoscopic sham procedures is substantial, and patients are subjected to considerable morbidity. These results raise a serious ethical dilemma regarding the use of sham-controlled trials.

Citing Articles

Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction.

Naing C, Ni H, Aung H, Pavlov C Cochrane Database Syst Rev. 2024; 3:CD014944.

PMID: 38517086 PMC: 10958761. DOI: 10.1002/14651858.CD014944.pub2.

Endoscopic Ultrasound-Guided Vascular Procedures: A Review.

Staudenmann D, Kaffes A, Saxena P Clin Endosc. 2020; 53(5):519-524.

PMID: 33027582 PMC: 7548160. DOI: 10.5946/ce.2020.222.

References

. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N Engl J Med. 1991; 324(25):1779-84. DOI: 10.1056/NEJM199106203242505. View

Mehta S, Myers T, Lonner J, Huffman G, Sennett B . The ethics of sham surgery in clinical orthopaedic research. J Bone Joint Surg Am. 2007; 89(7):1650-3. DOI: 10.2106/JBJS.F.00563. View

Gillett G . Unnecessary holes in the head. IRB. 2003; 23(6):1-6. View

Mathus-Vliegen E, Tytgat G . Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology. 1990; 99(2):362-9. DOI: 10.1016/0016-5085(90)91017-z. View

Albin R . Sham surgery controls are mitigated trolleys. J Med Ethics. 2005; 31(3):149-52. PMC: 1734102. DOI: 10.1136/jme.2003.006155. View

Laine L . Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial. N Engl J Med. 1987; 316(26):1613-7. DOI: 10.1056/NEJM198706253162601. View

Horng S, Miller F . Ethical framework for the use of sham procedures in clinical trials. Crit Care Med. 2003; 31(3 Suppl):S126-30. DOI: 10.1097/01.CCM.0000054906.49187.67. View

Miller F . Sham surgery: an ethical analysis. Sci Eng Ethics. 2004; 10(1):157-66. DOI: 10.1007/s11948-004-0073-x. View

Mathus-Vliegen E, van Weeren M, van Eerten P . Los function and obesity: the impact of untreated obesity, weight loss, and chronic gastric balloon distension. Digestion. 2003; 68(2-3):161-8. DOI: 10.1159/000075525. View

10.

Montgomery M, Hakanson B, Ljungqvist O, Ahlman B, Thorell A . Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study. Scand J Gastroenterol. 2006; 41(12):1382-9. DOI: 10.1080/00365520600735738. View

11.

Mathus-Vliegen E, Eichenberger R . Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg. 2013; 24(1):85-94. DOI: 10.1007/s11695-013-1053-5. View

12.

Bajbouj M, Becker V, Eckel F, Miehlke S, Pech O, Prinz C . Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology. 2009; 137(2):440-4. DOI: 10.1053/j.gastro.2009.04.053. View

13.

Polgar S, Ng J . Ethics, methodology and the use of placebo controls in surgical trials. Brain Res Bull. 2005; 67(4):290-7. DOI: 10.1016/j.brainresbull.2005.06.028. View

14.

Rutgeerts P, VANTRAPPEN G, BROECKAERT L, Coremans G, Janssens J, Hiele M . Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers. Lancet. 1989; 1(8648):1164-7. DOI: 10.1016/s0140-6736(89)92751-7. View

15.

Fockens P, Cohen L, Edmundowicz S, Binmoeller K, Rothstein R, Smith D . Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease. Surg Endosc. 2010; 24(6):1387-97. PMC: 2869435. DOI: 10.1007/s00464-009-0784-9. View

16.

Thompson C, Chand B, Chen Y, DeMarco D, Miller L, Schweitzer M . Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. Gastroenterology. 2013; 145(1):129-137.e3. DOI: 10.1053/j.gastro.2013.04.002. View

17.

Mathus-Vliegen E, de Groot G . Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity. Obes Surg. 2012; 23(5):622-33. DOI: 10.1007/s11695-012-0834-6. View

18.

. Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Hepatology. 1994; 20(3):618-25. View

19.

Eid G, McCloskey C, Eagleton J, Lee L, Courcoulas A . StomaphyX vs a sham procedure for revisional surgery to reduce regained weight in Roux-en-Y gastric bypass patients : a randomized clinical trial. JAMA Surg. 2014; 149(4):372-9. DOI: 10.1001/jamasurg.2013.4051. View

20.

Scolapio J, Gostout C, Schroeder K, Mahoney D, Lindor K . Dysphagia without endoscopically evident disease: to dilate or not?. Am J Gastroenterol. 2001; 96(2):327-30. DOI: 10.1111/j.1572-0241.2001.03514.x. View